{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":6,"sponsored":0,"items":[{"id":"n_7hr37jbkqpwx72jeaxbq","seq":1319139,"kind":"article","title":"Bergamo, 50enne con sclerosi multipla licenziato dopo calcetto in malattia: sarà risarcito","title_en":"Bergamo, 50-year-old with multiple sclerosis fired after playing soccer while on sick leave: will be compensated","url":"https://tg24.sky.it/cronaca/2026/10/02/licenziamento-dipendente-sclerosi-multipla-bergamo","summary":"Un cinquantenne, in cura per sclerosi multipla e sintomatologia ansiosa, era stato licenziato per giusta causa dopo essere stato visto giocare a calcetto durante la malattia. L’azienda lo aveva fatto seguire da un investigatore privato. Il Tribunale ha ritenuto il licenziamento non giustificato e gli ha riconosciuto 12 mensilità da 6mila euro lordi, senza reintegro","published":"2026-10-02T10:13:46Z","seen":"2026-10-02T10:13:46Z","lang":"it","country":"IT","source":{"id":"kite-tg24-sky-it-aff8df","name":"tg24.sky.it","domain":"tg24.sky.it","outlet":{"wikidata":"Q1174202","name":"Sky TG24","type":"other","country":"IT","designations":["specialty channel"]}},"via":"kite-tg24-sky-it-aff8df","entities":[{"id":"Q628","name":"Bergamo","type":"place"},{"id":"Q8277","name":"multiple sclerosis","type":"other"}],"image":"https://tg24.sky.it/assets/images/e74e5088acf3760ed10fb5a0822734ab9a75f335/social-cards/skytg24/2023/12/04/original-a4baee99-1a65-46b8-a48b-ad7d73c6fd8a-1.jpg","story":"st_7hr37jbkqpwx72jeaxbq","category":"crime-law","category_p":0.5,"sentiment":"negative","tone":-0.49,"political":0.01},{"id":"n_sgdtssfvscghhfrh3ipq","seq":1319689,"kind":"article","title":"濠·뉴질랜드 연구진, 다발성 경화증(MS) 치료 연구 도울 '미니 뇌' 개발","title_en":"New Zealand research team develops'mini brain' to aid multiple sclerosis treatment research","url":"https://www.newsis.com/view/NISX20261002_0003813211","summary":"[멜버른(호주)=신화/뉴시스] 유세진 기자 = 호주와 뉴질랜드 연구진이 전 세계 약 300만명에게 영향을 미치는 자가면역 질환인 다발성 경화증(MS) 치료법 연구를 가속화할 것으로 기대되는 3D '미니 뇌'를 개발했다. 호주 플로리 신경과학 및 정신건강 연구소는 2일 연구팀이 재프로그래밍된 성체 줄기세포를 이용해 쌀알 크기 정도의 인간 유사 중추신경계 세포 모델을 제작했다고 성명을 통해 밝혔다. '네이처 뉴로사이언스'에 발표된 연구에 따르면, '미니 브레인' 세포 모델은 인간 세포 내 미엘린 파괴와 재생 과정을 세밀하게 관찰할 수 있게 해주며, 연구자들이 약물이 인간 세포에서 거의 실시간으로 작용하는 모습을 볼 수 있게 해준다. 미엘린은 신경섬유를 감싸 보호하는 지방질 외피로, 전기 신호를 통해 뇌, 척수, 그리고 몸 전체로 메시지가 빠르게 전달되게 해준다. 연구진에 따르면 MS에서는 면역체계가 실수로 미엘린을 공격해 신경 손상과 장애를…","published":"2026-10-02T10:10:56Z","seen":"2026-10-02T10:17:48Z","lang":"ko","country":"KR","source":{"id":"kite-newsis-com-f17fa3","name":"newsis.com","domain":"newsis.com","outlet":{"wikidata":"Q12590695","name":"Newsis News Agency","type":"news_agency","country":"KR","designations":["news agency"]}},"via":"kite-newsis-com-f17fa3","authors":["유세진 기자"],"entities":[{"id":"Q664","name":"New Zealand","type":"place"},{"id":"Q8277","name":"multiple sclerosis","type":"other"}],"story":"st_sgdtssfvscghhfrh3ipq","category":"health","category_p":0.56,"category2":"science-technology","sentiment":"positive","tone":0.51,"political":0.02},{"id":"n_mvb63jwrrqz27d2yjmoa","seq":829241,"kind":"article","title":"F. Hoffmann-La Roche Ltd: Roche's fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis","url":"https://www.finanznachrichten.de/nachrichten-2026-09/69711776-f-hoffmann-la-roche-ltd-roche-s-fenebrutinib-is-the-first-btk-inhibitor-to-receive-u-s-fda-filing-acceptance-in-both-relapsing-and-primary-progress-399.htm","published":"2026-09-30T05:22:42Z","seen":"2026-09-30T05:22:42Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","politics","health","science"],"authors":["GlobeNewswire (Europe)"],"entities":[{"id":"Q2160232","name":"Roche","type":"org"},{"id":"Q23304817","name":"fenebrutinib","type":"other"},{"id":"Q8277","name":"multiple sclerosis","type":"other"}],"story":"st_vh6kljddlfk7232w24zq","category":"health","category_p":0.58,"sentiment":"neutral","tone":-0.28,"political":0.1},{"id":"n_cx3jeqzei7hdkan4hpfq","seq":832203,"kind":"article","title":"Roche's fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis","url":"https://www.manilatimes.net/2026/09/30/tmt-newswire/globenewswire/roches-fenebrutinib-is-the-first-btk-inhibitor-to-receive-us-fdafiling-acceptance-in-both-relapsing-and-primary-progressive-multiple-sclerosis/2435722","published":"2026-09-30T05:12:00Z","seen":"2026-09-30T05:40:22Z","lang":"en","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health","politics","science"],"entities":[{"id":"Q2160232","name":"Roche","type":"org"},{"id":"Q23304817","name":"fenebrutinib","type":"other"},{"id":"Q423572","name":"Bruton's tyrosine kinase","type":"other"},{"id":"Q8277","name":"multiple sclerosis","type":"other"}],"story":"st_vh6kljddlfk7232w24zq","category":"health","category_p":0.6,"sentiment":"positive","tone":-0.17,"political":0.12},{"id":"n_vh6kljddlfk7232w24zq","seq":826959,"kind":"press_release","title":"Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis","url":"https://www.globenewswire.com/news-release/2026/09/30/3371506/0/en/roche-s-fenebrutinib-is-the-first-btk-inhibitor-to-receive-u-s-fda-filing-acceptance-in-both-relapsing-and-primary-progressive-multiple-sclerosis.html","summary":"Basel, 30 September 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the United States Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) under priority review for fenebrutinib, an investigational non-covalent Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The filing acceptance is based on data from the comprehensive…","published":"2026-09-30T05:00:00Z","seen":"2026-09-30T05:10:18Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business","swx:ro","otc markets:rhhby","swx:rog","ch0012032113","us7711951043","ch0012032048","9015"],"entities":[{"id":"Q2160232","name":"Roche","type":"org"},{"id":"Q23304817","name":"fenebrutinib","type":"other"},{"id":"Q8277","name":"multiple sclerosis","type":"other"}],"mentions":2,"story":"st_vh6kljddlfk7232w24zq","category":"health","category_p":0.59,"sentiment":"positive","tone":0.28,"political":0.13},{"id":"n_tinp6mlqiv462zaxc4wq","seq":595969,"kind":"article","title":"Bylinkobraní provonělo zahradu u Domova sv. Josefa, který pomáhá lidem s roztroušenou sklerózou","title_en":"Herb gathering scented the garden at the St. Joseph's Home, which helps people with multiple sclerosis","url":"https://www.novinky.cz/clanek/domaci-zpravy-kralovehradecky-kraj-bylinkobrani-provonelo-zahradu-u-domova-sv-josefa-ktery-pomaha-lidem-s-roztrousenou-sklerozou-40599800","summary":"Léčivé bylinky se sbírají do časného jara, slavit v tuto dobu „bylinkobraní“ je proto už téměř pozdě. Přesto se v areálu Domova sv. Josefa v Žírči na Královédvorsku akce zvaná Bylinkobraní uskutečnila už po osmé. Nemá pouze upozornit na benefity léčivých rostlin a propagovat zdravý životní styl, ale přispívá i k většímu povědomí o nemoci roztroušená skleróza. Právě pro klienty s touto diagnózou je zdejší zařízení jako jediné u nás zbudováno.","published":"2026-09-29T06:25:40Z","seen":"2026-09-29T06:37:44Z","lang":"cs","country":"CZ","source":{"id":"kite-novinky-cz-600972","name":"novinky.cz","domain":"novinky.cz","outlet":{"wikidata":"Q7064916","name":"novinky.cz","type":"newspaper","country":"CZ","designations":["online newspaper"]}},"via":"kite-novinky-cz-600972","entities":[{"id":"Q23074300","name":"St. Joseph's Home","type":"org"},{"id":"Q8277","name":"multiple sclerosis","type":"other"}],"story":"st_tinp6mlqiv462zaxc4wq","category":"society","category_p":0.31,"sentiment":"positive","tone":0.47,"political":0.07}]}